These and our recent findings highlight that tumour promoting mechanisms supported jointly by lactate and 2-HG oncometabolites – regulated by mTOR dependent translational effects –, and especially the role of metabolic crossroads would be a promising approach to recognise a set of molecular targets for anticancer therapy. Here, MTOR is linked to neoplasm.